annual EBIT:
$8.67B+$212.28M(+2.51%)Summary
- As of today (April 13, 2025), SNY annual earnings before interest & taxes is $8.67 billion, with the most recent change of +$212.28 million (+2.51%) on December 1, 2024.
- During the last 3 years, SNY annual EBIT has fallen by -$1.02 billion (-10.50%).
- SNY annual EBIT is now -46.58% below its all-time high of $16.23 billion, reached on December 31, 2020.
Performance
SNY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$1.38B-$2.76B(-66.66%)Summary
- As of today (April 13, 2025), SNY quarterly earnings before interest & taxes is $1.38 billion, with the most recent change of -$2.76 billion (-66.66%) on December 1, 2024.
- Over the past year, SNY quarterly EBIT has stayed the same.
- SNY quarterly EBIT is now -87.01% below its all-time high of $10.64 billion, reached on March 31, 2008.
Performance
SNY quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$8.91B+$1.54B(+20.95%)Summary
- As of today (April 13, 2025), SNY TTM earnings before interest & taxes is $8.91 billion, with the most recent change of +$1.54 billion (+20.95%) on December 1, 2024.
- Over the past year, SNY TTM EBIT has stayed the same.
- SNY TTM EBIT is now -33.70% below its all-time high of $13.44 billion, reached on June 30, 2020.
Performance
SNY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SNY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | 0.0% | 0.0% |
| 3 y3 years | -10.5% | -48.9% | -10.0% |
| 5 y5 years | +140.7% | -48.9% | -10.0% |
SNY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | +2.5% | -68.2% | +955.2% | -31.0% | +29.6% |
| 5 y | 5-year | -46.6% | +140.7% | -84.5% | +955.2% | -33.7% | +110.4% |
| alltime | all time | -46.6% | +738.4% | -87.0% | +106.4% | -33.7% | +250.1% |
Sanofi EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.67B(+2.5%) | $1.38B(-66.7%) | $8.91B(+21.0%) |
| Sep 2024 | - | $4.14B(+152.0%) | $7.36B(+7.2%) |
| Jun 2024 | - | $1.64B(-5.4%) | $6.87B(-6.3%) |
| Mar 2024 | - | $1.74B(-1175.9%) | $7.33B(-12.8%) |
| Dec 2023 | $8.46B(-26.3%) | -$161.54M(-104.4%) | $8.41B(-34.9%) |
| Sep 2023 | - | $3.65B(+73.5%) | $12.91B(+7.1%) |
| Jun 2023 | - | $2.10B(-25.3%) | $12.06B(+4.8%) |
| Mar 2023 | - | $2.82B(-35.1%) | $11.51B(+1.0%) |
| Dec 2022 | $11.48B(+18.5%) | $4.34B(+55.2%) | $11.39B(+29.5%) |
| Sep 2022 | - | $2.80B(+80.3%) | $8.80B(-8.2%) |
| Jun 2022 | - | $1.55B(-42.6%) | $9.58B(-3.2%) |
| Mar 2022 | - | $2.70B(+54.5%) | $9.90B(+2.1%) |
| Dec 2021 | $9.69B(-40.3%) | $1.75B(-51.1%) | $9.69B(+22.0%) |
| Sep 2021 | - | $3.58B(+91.3%) | $7.94B(+81.9%) |
| Jun 2021 | - | $1.87B(-25.1%) | $4.37B(-61.7%) |
| Mar 2021 | - | $2.50B(-72.0%) | $11.41B(-15.1%) |
| Dec 2020 | $16.23B(+350.7%) | - | - |
| Jun 2020 | - | $8.92B(+290.5%) | $13.44B(+217.4%) |
| Mar 2020 | - | $2.28B(-1474.6%) | $4.23B(+17.3%) |
| Dec 2019 | $3.60B(-37.8%) | -$166.10M(-106.9%) | $3.61B(-1.5%) |
| Sep 2019 | - | $2.40B(-938.8%) | $3.67B(-17.6%) |
| Jun 2019 | - | -$286.47M(-117.3%) | $4.45B(-24.4%) |
| Mar 2019 | - | $1.66B(-1599.6%) | $5.88B(+1.1%) |
| Dec 2018 | $5.79B(-14.1%) | -$110.67M(-103.5%) | $5.82B(-15.0%) |
| Sep 2018 | - | $3.18B(+177.5%) | $6.84B(+13.8%) |
| Jun 2018 | - | $1.15B(-28.0%) | $6.01B(-6.5%) |
| Mar 2018 | - | $1.59B(+74.5%) | $6.43B(-4.0%) |
| Dec 2017 | $6.74B(-7.7%) | $913.81M(-61.2%) | $6.70B(-10.2%) |
| Sep 2017 | - | $2.36B(+50.6%) | $7.46B(-4.3%) |
| Jun 2017 | - | $1.56B(-16.0%) | $7.79B(-1.3%) |
| Mar 2017 | - | $1.86B(+11.4%) | $7.89B(+7.9%) |
| Dec 2016 | $7.30B(+13.4%) | $1.67B(-37.7%) | $7.31B(+21.0%) |
| Sep 2016 | - | $2.69B(+61.4%) | $6.04B(+8.8%) |
| Jun 2016 | - | $1.67B(+29.5%) | $5.55B(-8.3%) |
| Mar 2016 | - | $1.29B(+218.6%) | $6.05B(-3.5%) |
| Dec 2015 | $6.44B(-22.6%) | $403.73M(-81.6%) | $6.27B(-20.6%) |
| Sep 2015 | - | $2.20B(+1.5%) | $7.90B(-2.3%) |
| Jun 2015 | - | $2.16B(+43.6%) | $8.09B(+5.0%) |
| Mar 2015 | - | $1.51B(-25.8%) | $7.70B(-7.2%) |
| Dec 2014 | $8.32B(+23.0%) | $2.03B(-14.8%) | $8.30B(+3.9%) |
| Sep 2014 | - | $2.38B(+34.0%) | $7.99B(+2.5%) |
| Jun 2014 | - | $1.78B(-15.4%) | $7.79B(+12.5%) |
| Mar 2014 | - | $2.10B(+22.0%) | $6.93B(+2.2%) |
| Dec 2013 | $6.76B | $1.72B(-21.2%) | $6.77B(+21.1%) |
| Sep 2013 | - | $2.19B(+138.7%) | $5.59B(-9.5%) |
| Jun 2013 | - | $915.61M(-53.1%) | $6.18B(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $1.95B(+260.7%) | $7.37B(-11.9%) |
| Dec 2012 | $8.39B(+0.2%) | $540.92M(-80.5%) | $8.37B(-10.4%) |
| Sep 2012 | - | $2.78B(+32.1%) | $9.34B(-5.7%) |
| Jun 2012 | - | $2.10B(-28.8%) | $9.91B(+5.0%) |
| Mar 2012 | - | $2.95B(+94.6%) | $9.44B(+12.7%) |
| Dec 2011 | $8.37B(-4.9%) | $1.52B(-54.7%) | $8.38B(+4.4%) |
| Sep 2011 | - | $3.34B(+105.6%) | $8.02B(+16.7%) |
| Jun 2011 | - | $1.63B(-13.9%) | $6.88B(-16.3%) |
| Mar 2011 | - | $1.89B(+62.4%) | $8.22B(-10.3%) |
| Dec 2010 | $8.80B(-1.2%) | $1.16B(-47.1%) | $9.16B(-7.8%) |
| Sep 2010 | - | $2.20B(-25.9%) | $9.93B(-3.1%) |
| Jun 2010 | - | $2.97B(+4.8%) | $10.25B(+13.7%) |
| Mar 2010 | - | $2.83B(+46.3%) | $9.02B(+1.8%) |
| Dec 2009 | $8.91B(+35.0%) | $1.94B(-23.1%) | $8.86B(+182.7%) |
| Sep 2009 | - | $2.52B(+45.2%) | $3.13B(-30.9%) |
| Jun 2009 | - | $1.73B(-35.1%) | $4.54B(-14.1%) |
| Mar 2009 | - | $2.67B(-170.5%) | $5.28B(-60.1%) |
| Dec 2008 | $6.60B(-21.1%) | -$3.79B(-196.7%) | $13.24B(-382.6%) |
| Sep 2008 | - | $3.92B(+58.0%) | -$4.69B(-578.0%) |
| Jun 2008 | - | $2.48B(-76.7%) | $980.43M(+31.6%) |
| Mar 2008 | - | $10.64B(-149.0%) | $744.95M(-215.7%) |
| Dec 2007 | $8.36B(+10.9%) | -$21.72B(-326.6%) | -$643.73M(-316.8%) |
| Sep 2007 | - | $9.59B(+327.0%) | $296.96M(+249.9%) |
| Jun 2007 | - | $2.25B(-75.7%) | $84.87M(-110.8%) |
| Mar 2007 | - | $9.25B(-144.5%) | -$783.24M(-86.8%) |
| Dec 2006 | $7.54B(+6.0%) | -$20.78B(-321.7%) | -$5.94B(-158.4%) |
| Sep 2006 | - | $9.37B(+580.8%) | $10.16B(+97.2%) |
| Jun 2006 | - | $1.38B(-66.4%) | $5.15B(-7.4%) |
| Mar 2006 | - | $4.09B(-187.5%) | $5.56B(-17.3%) |
| Dec 2005 | $7.12B(+60.0%) | -$4.68B(-207.3%) | $6.73B(+95.2%) |
| Sep 2005 | - | $4.36B(+144.1%) | $3.45B(-38.5%) |
| Jun 2005 | - | $1.79B(-66.0%) | $5.61B(+18.3%) |
| Mar 2005 | - | $5.26B(-166.0%) | $4.74B(+109.6%) |
| Dec 2004 | $4.45B(+28.0%) | -$7.96B(-222.1%) | $2.26B(-64.8%) |
| Sep 2004 | - | $6.52B(+608.2%) | $6.42B(+145.2%) |
| Jun 2004 | - | $921.24M(-66.9%) | $2.62B(+5.3%) |
| Mar 2004 | - | $2.78B(-173.1%) | $2.49B(+38.7%) |
| Dec 2003 | $3.48B(+40.4%) | -$3.81B(-239.9%) | $1.79B(-32.1%) |
| Sep 2003 | - | $2.72B(+244.4%) | $2.64B(+50.0%) |
| Jun 2003 | - | $789.90M(-62.2%) | $1.76B(+14.5%) |
| Mar 2003 | - | $2.09B(-170.6%) | $1.54B(-379.6%) |
| Dec 2002 | $2.48B(+31.2%) | -$2.96B(-260.7%) | -$549.94M(-122.9%) |
| Sep 2002 | - | $1.84B(+224.9%) | $2.41B(+324.9%) |
| Jun 2002 | - | $566.21M | $566.21M |
| Dec 2001 | $1.89B(+29.5%) | - | - |
| Dec 2000 | $1.46B(+40.9%) | - | - |
| Dec 1999 | $1.03B | - | - |
FAQ
- What is Sanofi annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sanofi?
- What is Sanofi annual EBIT year-on-year change?
- What is Sanofi quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sanofi?
- What is Sanofi quarterly EBIT year-on-year change?
- What is Sanofi TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sanofi?
- What is Sanofi TTM EBIT year-on-year change?
What is Sanofi annual earnings before interest & taxes?
The current annual EBIT of SNY is $8.67B
What is the all time high annual EBIT for Sanofi?
Sanofi all-time high annual earnings before interest & taxes is $16.23B
What is Sanofi annual EBIT year-on-year change?
Over the past year, SNY annual earnings before interest & taxes has changed by +$212.28M (+2.51%)
What is Sanofi quarterly earnings before interest & taxes?
The current quarterly EBIT of SNY is $1.38B
What is the all time high quarterly EBIT for Sanofi?
Sanofi all-time high quarterly earnings before interest & taxes is $10.64B
What is Sanofi quarterly EBIT year-on-year change?
Over the past year, SNY quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Sanofi TTM earnings before interest & taxes?
The current TTM EBIT of SNY is $8.91B
What is the all time high TTM EBIT for Sanofi?
Sanofi all-time high TTM earnings before interest & taxes is $13.44B
What is Sanofi TTM EBIT year-on-year change?
Over the past year, SNY TTM earnings before interest & taxes has changed by $0.00 (0.00%)